about
Sick sinus syndrome associated with hypopituitarism: a case report and literature review.The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytesPotential phytoestrogen alternatives exert cardio-protective mechanisms via estrogen receptorsHormonal regulation of cardiac KCNE2 gene expression.Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytesOestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist.Ospemifene use in postmenopausal women.Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation.Sex-related changes in cardiac function following myocardial infarction in mice.Myocardial AKT: the omnipresent nexus.Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt.Estrogen receptor beta as a mitochondrial vulnerability factorNuclear and mitochondrial signalling Akts in cardiomyocytesThe Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.Mitochondrial p38β and manganese superoxide dismutase interaction mediated by estrogen in cardiomyocytes.Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis.Impact of estradiol on insulin signaling in the rat heart.Does oestradiol attenuate the damaging effects of a fructose-rich diet on cardiac Akt/endothelial nitric oxide synthase signalling?Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats.
P2860
Q33164887-787FDF4B-4B73-47B7-8CA7-7C40362EC52EQ33815579-F30E0F83-E1B1-42B0-8BB7-BC0D274B1B1AQ33821464-F8A12746-C67B-4782-B323-A8D5F19F990FQ33945450-D6A74882-C088-4B7C-9541-EC0EC58F7047Q34132206-97491D8F-5A44-43B1-BCD4-3502EE791282Q34409624-9D823478-A21B-4983-98D2-989E707D3B81Q34696040-BC1DA4CF-2DCA-44B5-A4A2-2FC500457F26Q34779992-B8D11FF4-09A6-4AB7-9B7B-A01D8B371F7AQ34982860-47E490C6-2C01-417A-9B56-D0A58ADAE502Q36802938-82E6DA76-97F4-422B-87AC-F94D0AF7EF3FQ36846731-A583769E-9FED-49B5-A69E-6669CB562CD1Q36908289-F44D72D8-FC2B-4021-8AA4-5C47E1F4323DQ37000868-0E43E1B9-77DD-4E94-BC56-709448B6C3CAQ37152893-5112278D-3A66-4497-AFC2-E48FD555B439Q37176193-9D487C41-7B07-4AB9-A21F-92015157A3ECQ37234859-44C02775-D648-4ABD-848B-468D4D4CA9D2Q37504948-DF614DAE-E0E3-4174-9DCE-D13F2E7126C6Q39788803-CB88AB95-4C75-4848-AB03-FD025E5C43E2Q42449642-8469E786-17CA-4276-9D88-9D67E5B94630Q45931829-5AB35E1F-3794-433C-99CC-27731169A39AQ51012946-E6202632-DBDB-4AE0-9267-AF2754531A7E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Estrogen replacement and cardiomyocyte protection.
@ast
Estrogen replacement and cardiomyocyte protection.
@en
type
label
Estrogen replacement and cardiomyocyte protection.
@ast
Estrogen replacement and cardiomyocyte protection.
@en
prefLabel
Estrogen replacement and cardiomyocyte protection.
@ast
Estrogen replacement and cardiomyocyte protection.
@en
P1476
Estrogen replacement and cardiomyocyte protection.
@en
P2093
Richard D Patten
Richard H Karas
P356
10.1016/J.TCM.2006.01.002
P577
2006-04-01T00:00:00Z